Stock 000078 SHENZHEN NEPTUNUS BIOENGINEERING CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Shenzhen Neptunus Bioengineering Co., Ltd.

Equities

000078

CNE000000X95

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 09/05/2024 BST 		5-day change 1st Jan Change
2.48 CNY -1.98% Intraday chart for Shenzhen Neptunus Bioengineering Co., Ltd. +6.44% -21.02%
04-29 Shenzhen Neptunus Bioengineering Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-29 Shenzhen Neptunus Bioengineering Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 7,887 10,304 11,031 9,710 9,133 8,638
Enterprise Value (EV) 1 16,272 17,144 19,732 18,128 17,353 16,361
P/E ratio 19.1 x 41 x -36.5 x 88.3 x -8.5 x -4.89 x
Yield 0.67% - - - - -
Capitalization / Revenue 0.21 x 0.25 x 0.28 x 0.24 x 0.24 x 0.24 x
EV / Revenue 0.42 x 0.41 x 0.49 x 0.44 x 0.46 x 0.45 x
EV / EBITDA 8.17 x 7.34 x 10.3 x 11.2 x 18.9 x 15.1 x
EV / FCF -11.1 x 36.7 x -13.4 x 19.1 x 50 x 8.56 x
FCF Yield -9.04% 2.73% -7.47% 5.24% 2% 11.7%
Price to Book 1.33 x 1.65 x 1.88 x 1.67 x 1.95 x 2.38 x
Nbr of stocks (in thousands) 2,646,613 2,762,583 2,750,833 2,750,833 2,750,833 2,750,833
Reference price 2 2.980 3.730 4.010 3.530 3.320 3.140
Announcement Date 26/04/19 27/04/20 26/04/21 28/04/22 27/04/23 29/04/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 38,381 41,493 40,022 41,054 37,835 36,419
EBITDA 1 1,991 2,334 1,918 1,616 920.1 1,083
EBIT 1 1,859 2,198 1,739 1,458 763.3 885.5
Operating Margin 4.84% 5.3% 4.35% 3.55% 2.02% 2.43%
Earnings before Tax (EBT) 1 1,006 927 267.4 576.3 -853.2 -1,458
Net income 1 414.7 241 -288.5 93.3 -1,027 -1,690
Net margin 1.08% 0.58% -0.72% 0.23% -2.72% -4.64%
EPS 2 0.1560 0.0910 -0.1100 0.0400 -0.3905 -0.6423
Free Cash Flow 1 -1,471 467.3 -1,475 950.1 347.2 1,912
FCF margin -3.83% 1.13% -3.68% 2.31% 0.92% 5.25%
FCF Conversion (EBITDA) - 20.02% - 58.78% 37.73% 176.45%
FCF Conversion (Net income) - 193.92% - 1,018.37% - -
Dividend per Share 2 0.0200 - - - - -
Announcement Date 26/04/19 27/04/20 26/04/21 28/04/22 27/04/23 29/04/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 8,385 6,840 8,702 8,418 8,220 7,723
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 4.211 x 2.93 x 4.537 x 5.208 x 8.934 x 7.129 x
Free Cash Flow 1 -1,471 467 -1,475 950 347 1,912
ROE (net income / shareholders' equity) 10.2% 7.39% -0.54% 3.49% -14.8% -33.3%
ROA (Net income/ Total Assets) 3.23% 3.34% 2.69% 2.36% 1.29% 1.61%
Assets 1 12,845 7,217 -10,736 3,959 -79,524 -104,666
Book Value Per Share 2 2.250 2.260 2.140 2.120 1.710 1.320
Cash Flow per Share 2 1.550 2.230 1.950 1.500 1.130 1.530
Capex 1 214 168 147 129 94.3 104
Capex / Sales 0.56% 0.4% 0.37% 0.31% 0.25% 0.29%
Announcement Date 26/04/19 27/04/20 26/04/21 28/04/22 27/04/23 29/04/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
SHENZHEN NEPTUNUS BIOENGINEERING CO., LTD. Stock Shenzhen Neptunus Bioengineering Co., Ltd.
-21.02% 964M
MCKESSON CORPORATION Stock McKesson Corporation
+20.72% 72.16B
CARDINAL HEALTH, INC. Stock Cardinal Health, Inc.
-0.87% 23.88B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+8.25% 8.35B
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
+5.13% 8.29B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-19.42% 8.18B
H. LUNDBECK A/S Stock H. Lundbeck A/S
+5.56% 4.81B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
+16.83% 4.4B
EBOS GROUP LIMITED Stock EBOS Group Limited
-1.83% 4B
GALENICA AG Stock Galenica AG
-1.65% 3.92B
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. 000078 Stock
  4. Financials Shenzhen Neptunus Bioengineering Co., Ltd.